- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Sep 30, 2021
Highlights
- Market Cap
- $14.08M
- Enterprise Value
- $8.65M
- EPS (TTM)
- -$0.46
- Total Revenue (TTM)
- $28.94M
- Gross Profit (TTM)
- $23.97M
- EBITDA (TTM)
- -$33.26M
- Year Range
- $0.05 - $0.30
- ROA (TTM)
- -18.49%
- ROE (TTM)
- -20.67%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
OABIW Performance Chart
OmniAb Inc. (OABIW) is down 8.4% since the beginning of the year. At $0 per share, OABIW is trading 63.4% below its 52-week high of $0.
Loading charts...
Returns By Period
OmniAb Inc. (OABIW) has returned -8.42% so far this year and -55.90% over the past 12 months.
OmniAb Inc.
- 1D
- -5.99%
- 1M
- -4.52%
- YTD
- -8.42%
- 6M
- -8.42%
- 1Y
- -55.90%
- 3Y*
- -46.32%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
OABIW Monthly Returns History
Based on dividend-adjusted daily data since Sep 30, 2021, OABIW's average daily return is +0.31%, while the average monthly return is +0.97%. At this rate, an investment would double in approximately 6.0 years.
Historically, 38% of months were positive and 62% were negative. The best month was Dec 2023 with a return of +77.6%, while the worst month was Nov 2022 at -47.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.
On a daily basis, OABIW closed higher 27% of trading days. The best single day was Mar 24, 2022 with a return of +96.5%, while the worst single day was Nov 2, 2022 at -49.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.42% | -19.19% | -10.81% | 46.88% | -14.89% | 9.80% | -8.42% | ||||||
| 2025 | 16.18% | 29.37% | -26.99% | -6.19% | -42.86% | -13.45% | 67.53% | -28.69% | -17.79% | -2.94% | -22.67% | -6.03% | -64.74% |
| 2024 | 11.65% | -17.04% | -26.36% | -11.91% | -3.05% | -23.77% | 0.59% | -4.37% | -7.94% | -25.92% | 0.13% | 13.18% | -66.99% |
| 2023 | 27.27% | -1.24% | -20.12% | -27.54% | 52.46% | 26.23% | 32.47% | 15.68% | -11.38% | -29.22% | -21.63% | 77.59% | 87.27% |
| 2022 | -35.36% | -12.28% | 66.41% | -6.79% | -27.58% | -29.79% | 43.36% | 16.25% | -9.09% | 51.82% | -47.31% | 37.50% | -25.46% |
| 2021 | 0.00% | 20.00% | -7.58% | 20.97% | 34.16% |
Benchmark Metrics
OmniAb Inc. has an annualized alpha of 105.67%, beta of 0.44, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since September 30, 2021.
- This stock participated in 173.34% of S&P 500 Index downside but only 8.02% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.44 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 105.67%
- Beta
- 0.44
- R²
- 0.00
- Upside Capture
- 8.02%
- Downside Capture
- 173.34%
Return for Risk
Risk / Return Rank
OABIW ranks 34 for risk / return — below 34% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for OmniAb Inc. (OABIW) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| OABIW | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.35 | ||
| Sortino ratioReturn per unit of downside risk | -2.09 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.37 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | -0.71 | 2.78 | -3.50 |
| Martin ratioReturn relative to average drawdown | -1.01 | 12.44 | -13.45 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the OmniAb Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the OmniAb Inc. was 95.66%, occurring on May 11, 2026. The portfolio has not yet recovered.
The current OmniAb Inc. drawdown is 92.56%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -95.66%May 2026 | 2y 9mo | — | 2y 10moAug 2023 - now |
Bear market2022 | -70.65%Mar 2022 | 2mo 10d | 7mo 19d | 9mo 29dJan 2022 - Oct 2022 |
Bear market2022 | -53.89%Nov 2022 | 1d | 8mo | 8mo 1dNov 2022 - Jun 2023 |
2021 bear market2021 | -21.13%Dec 2021 | 1mo 19d | 3d | 1mo 22dNov 2021 - Dec 2021 |
2021 correction2021 | -12.03%Oct 2021 | 8d | 6d | 14dOct 2021 - Oct 2021 |
Drawdown Indicators
| OABIW | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.66% | -56.78% | -38.88% |
Max Drawdown (1Y)Largest decline over 1 year | -78.67% | -9.10% | -69.57% |
Max Drawdown (3Y)Largest decline over 3 years | -95.66% | -18.90% | -76.76% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -92.56% | -1.80% | -90.76% |
Average DrawdownAverage peak-to-trough decline | -52.41% | -10.71% | -41.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 55.27% | 2.03% | +53.24% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of OmniAb Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how OmniAb Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for OABIW relative to other companies in the Biotechnology industry. Currently, OABIW has a P/S ratio of 0.5. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for OABIW in comparison with other companies in the Biotechnology industry. Currently, OABIW has a P/B value of 0.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with OABIW
Add OmniAb Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with OABIW